ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
复制标题
对于患有冠状动脉疾病的认知健康受试者，α-3 乙酯在 12 个月和 30 个月时比对照组具有更好的认知功能：随机临床试验的二次分析。
DOI：
10.1093/ajcn/nqaa420
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Welty,FrancineK
中科院分区：
文献类型：
--
作者：
Malik,Abdulaziz;Ramadan,Amira;Vemuri,Bhavya;Siddiq,Wardah;Amangurbanova,Maral;Ali,Aamir;Welty,FrancineK
